Evaluating the Outcomes for Incisional Application of Negative Pressure for Nontraumatic Amputations
NCT ID: NCT03250442
Last Updated: 2019-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
112 participants
INTERVENTIONAL
2017-11-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Closed Incision Negative Pressure Dressing (PREVENA) to Prevent Lower Extremity Amputation Wound Complications
NCT03773575
CiNPWT Lower Extremity Amputations (Closed Incision Neagtive Pressure Wound Therapy)
NCT06493539
Negative Pressure Wound Therapy for Surgical Wounds of the Foot and Ankle
NCT02739191
Additional Hyperbaric Oxygen After Lower Extremity Amputation
NCT03594344
The Safety of Reusing Walking Boot Components for Patients Recovering From Acute Foot and Ankle Injuries
NCT07287969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: Standard Dry Dressing
The standard dry dressing is comprised of nonadherent dressing, dry gauze, cotton undercast padding, compression, and immobilization.
Standard Dry Dressing
These are customary dry dressings.
Group B: Foam, Drape, and PrevenaTM
This arm is comprised of foam, drape, the PrevenaTM Device, compression, and immobilization.
PrevenaTM Device
The PrevenaTM Incision Management System covers and protects the incision from external contamination, while negative pressure removes fluid and infectious material from the surgical incision.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PrevenaTM Device
The PrevenaTM Incision Management System covers and protects the incision from external contamination, while negative pressure removes fluid and infectious material from the surgical incision.
Standard Dry Dressing
These are customary dry dressings.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Requires closure of a nontrauamtic Transmetatarsal Amputation (TMA), Below Knee Amputation (BKA), Knee Disarticulation (KD), or Above Knee Amputation (AKA).
3. Has at least one artery that feeds the closure site.
4. Able to comply with clinical trial procedures and schedule.
Exclusion Criteria
2. The investigator/provider determines that the patient has an indication against incisional negative pressure wound therapy that would prevent them from participating.
3. Surgical incision that is not completely closed.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Georgetown University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christopher Attinger, M.D.
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher Attinger, MD
Role: PRINCIPAL_INVESTIGATOR
MedStar Georgetown University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Paul Kim, DPM
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-0599
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.